Explore chapters and articles related to this topic
Ayurveda in the West
Published in D. Suresh Kumar, Ayurveda in the New Millennium, 2020
One of the main reasons why Pañcakarma therapies are not used as per Caraka Samhita in Europe is that they are labor-intensive. This fact makes the cost of offering these therapies to the European public far beyond the average person’s budget. Additionally, the health insurance of most countries does not cover these kinds of procedures. Pañcakarma also requires a large quantity of botanicals to be therapeutically effective. According to Dr Sunil V. Joshi, director of the Vinayak Pañcakarma Chikitsalaya in Nagpur, India they use roughly 10 kilos of medicinal plants per patient, per week in Pañcakarma. This includes the fabrication of medicinal oils, pastes, enemas (Basti) as well as other preparations that are used in both preparation (Pūrvakarma) and administration of the primary therapies (Pradhānakarma). Dr Joshi is the author of the acclaimed book Ayurveda and Panchakarma (Joshi 1997). Between the cost of raw materials, the labor needed to fabricate the medicines and the labor needed to apply the therapies to the patient, the cost is too high to follow classical Pañcakarma guidelines.
Ayurvedic Medicine
Published in Aruna Bakhru, Nutrition and Integrative Medicine, 2018
Āma in the stomach is removed by vamana. Āma in the small intestine is removed by virechana, while that in the colon is eliminated by basti. If there is some lingering āma in the blood, then that can be removed by bloodletting, or the application of leeches. Vamana is for kapha dosha, virechana for pitta dosha, basti for vāta dosha, nasya for any residual dosha in the majjā dhātu, and rakta moksha removes āma from the hematopoietic system. Panchakarma is a part of a series of procedures called shodhana, detoxification. Shodhana makes the body free from āma.
A-Z of Standardisation, Pre-Clinical, Clinical and Toxicological Data
Published in Saroya Amritpal Singh, Regulatory and Pharmacological Basis of Ayurvedic Formulations, 2017
For this study, 118 patients of Amavata were randomly divided into two groups. The patients in group A (50 patients) were given Matra Basti with Brihat Saindhavadi Taila along with Vatari Guggulu; the patients in group B (53 patients) were given only Vatari Guggulu. All the patients responded favorably to the treatment in both the groups; however, patients treated with Matra Basti had better relief in most of the cardinal signs and symptoms of the disease (Khagram et al. 2010).
Occurrence of Occult Neoplasia in Pterygium Specimens Among Hispanic and Non-Hispanic Patients
Published in Current Eye Research, 2022
Christopher Zhu, Menachem Weiss, Frank W. Scribbick, Daniel A. Johnson, Ahmad Kheirkhah
The effects of race and ethnicity on the prevalence of OSSN alone have also been investigated. McClellan et al.9 reviewed the charts of over 24,000 patients from a Veterans Affairs eye center in Miami, Florida, and found that Whites and non-Hispanics were disproportionately affected by OSSN alone, but this finding did not reach statistical significance. A review of OSSN by Basti and Macsai23 suggested that the highest risk of OSSN is in older Caucasian men living near the equator. In the United States, the majority of cases of conjunctival squamous cell carcinoma were reported in Whites, though only 4% of this cohort was Black.24 In New Mexico, squamous cell carcinoma of the conjunctiva was significantly higher among Hispanic Whites (0.6/100,000) than among Anglo Whites (0.09/100,000; p < .05).25 In addition to race and ethnicity, other risk factors that may affect the varying prevalence of OSSN and pterygium in different communities include human immunodeficiency virus and human papilloma virus which were not evaluated in our series.26–30
Intraocular Lens Techniques in Pediatric Eyes with Insufficient Capsular Support: Complications and Outcomes
Published in Seminars in Ophthalmology, 2019
Crystal SY Cheung, Deborah K VanderVeen
Since Artisan IOLs were designed for anterior chamber placement, there is concern about ECL incurred during the lens insertion and long-term over a patient’s lifetime. Studies of ECL after cataract surgery in pediatric populations consist of case series and retrospective studies. The degree of ECL in children is estimated to be 6% three years after cataract surgery with PCIOLs and Hessberg-type anterior IOLs and can vary depending on age, technique, and indications for surgery.47 A prospective study by Basti et al.48 showed that rates of ECL ranged from to 5.3% to 7.5% following pediatric extracapsular cataract extraction with PCIOLs. A case-control study showed that the mean endothelial cell count was 11% lower with polymegathism and pleomorphism in eyes that had undergone cataract surgery compared to unoperated control eyes at mean intervals of 78 months after pediatric cataract surgery.49
Effect of Multi-Ingredient Supplement Containing Satiereal, Naringin, and Vitamin D on Body Composition, Mood, and Satiety in Overweight Adults
Published in Journal of Dietary Supplements, 2018
Adam M. Gonzalez, Katie M. Sell, Jamie J. Ghigiarelli, Robert W. Spitz, Matthew R. Accetta, Gerald T. Mangine
The effect of saffron on mood states has previously been investigated. Saffron treatment (30 mg·day−1 for 6 weeks) has led to significant improvements in the Hamilton depression scale in human subjects with mild-moderate depression compared to a placebo (Akhondzadeh et al., 2004; Akhondzadeh et al., 2005; Basti et al., 2007; Moshiri et al., 2006). The saffron extract, satiereal (176.5 mg·day−1 for 8 weeks), has also been shown to reduce snacking frequency and increase self-reported satiety in otherwise healthy overweight women (Gout et al., 2010). Notably, the reduction of snacking frequency (relative to baseline) was demonstrated with satiereal supplementation only following four weeks of supplementation (Gout et al., 2010). Satiereal supplementation also resulted in modest, yet significant, body weight reduction compared to placebo (−0.96 kg vs. −0.01 kg, respectively) (Gout et al., 2010). The mechanisms underlying these findings are unknown; however, saffron and its constituents have been shown to be involved in antagonistic activity at glutamate receptors in a rat model, potentially affecting central nervous system function and mood (Berger et al., 2011). In the current study, the multi-ingredient supplement did tend to promote greater, yet insignificant, feelings of satiety over the 28 days; however, supplementation did not have any significant effects on weight loss or waist circumference. Although speculative, it is possible that feelings of satiety may have been significantly altered following a longer supplementation period.